Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Porcine Fms related receptor tyrosine kinase 3 (FLT3) ELISA Kit-Sandwich

Name: Porcine Fms related receptor tyrosine kinase 3 (FLT3) ELISA Kit-Sandwich
SKU: EK9F890
Rating: 5 (1 reviews)

Cat. No.EK9F890

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Porcine FLT3 ELISA Kit-Sandwich is designed for the quantitative determination of Porcine fms related receptor tyrosine kinase 3 (FLT3) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Porcine FLT3.

Target Species Swine

Species Reactivity Swine

Detection Range 16-1000 pg/mL

Sensitivity 3.1 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Fms related receptor tyrosine kinase 3 is encoded by the FLT3 gene in pigs. It is a tyrosine kinase receptor of the platelet-derived growth factor receptor (PDGF-R) sub-family.

Target/Biomarker Porcine FLT3

Target Synonym fms related receptor tyrosine kinase 3; receptor-type tyrosine-protein kinase FLT3; fms related tyrosine kinase 3

Gene ID 100515445

UniProt ID A0A480ECT1

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Wood, F. L. et al. Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2019, 139: 104899.